Article ID Journal Published Year Pages File Type
5699335 Clinical Oncology 2010 11 Pages PDF
Abstract
Ongoing management recommendations must be tailored to realistic, evolving risk estimates that are actively updated during follow-up. By individualizing therapy on the basis of initial and ongoing risk assessments, we can maximize the beneficial effects of aggressive therapy in patients with thyroid cancer who are likely to benefit from it, while minimizing potential complications and side effects in low-risk patients destined to have a full healthy and productive life after minimal therapeutic intervention.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, ,